Ellen Matloff

6.1k citations

45 papers · 4.0k indexed · 2 hit papers · h-index 22

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Genetics top 0.2%
- BRCA gene mutations in cancer
- Genomic variations and chromosomal abnormalities

Papers in

Genetics 38
- BRCA gene mutations in cancer 37
- Genomics and Rare Diseases 7
- Genomic variations and chromosomal abnormalities 7
Cancer Research 10
- Cancer Genomics and Diagnostics 7
- Breast Cancer Treatment Studies 4

Co-authors: D. Gareth Evans Claudine Isaacs Henry T. Lynch Susan L. Neuhausen Timothy R. Rebbeck Mary B. Daly Olufunmilayo I. Olopade Judy E. Garber
Journals: The Cancer Journal (6 papers)Journal of Clinical Oncology (6 papers)Familial Cancer (2 papers)The American Journal of Managed Care (2 papers)The Lancet (2 papers)
Partner nations: United States United Kingdom Austria

In The Last Decade

Ellen Matloff

45 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group 2004 · 812 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Journal of Clinical Oncology
2002 New England Journal of Medicine

Peers

Countries citing papers authored by Ellen Matloff

Since Specialization

Citations

This map shows the geographic impact of Ellen Matloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Matloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Matloff more than expected).

Fields of papers citing papers by Ellen Matloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Matloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Matloff. The network helps show where Ellen Matloff may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ellen Matloff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ellen Matloff Line = papers co-authored together Ellen Matloff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results BMC Cancer ·Deborah Cragun, Jason W. Beckstead, Meagan Farmer, Gillian W. Hooker, Marleah Dean, Ellen Matloff, Sonya Reid, Egil Antonsen, Anne Weidner, Jennifer G. Whisenant, Tuya Pal	2021	5
2	Errors in Genetic Testing: The Fourth Case Series The Cancer Journal ·Meagan Farmer, A. M Adeyemi, Suzanne M. Mahon, Maria J. Baker, Nils-Petter Thorup, Kudratova Yulduz, Вікторія Володимирівна Лемещенко, Andria G. Besser, J. Jeba Johnsly, Sachinrao Jupally, R Johnayro Gutiérrez, C SMITH, 堀家康太, Jessica Sebastian, J. Nicoll, 千佳今福, Ellen Matloff	2019	38
3	Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients The Breast Journal ·K. Bløtekjaer, Lesley Cheema, Olga Voznesensky, Ellen Matloff, Erin Hofstatter, Steven P. Balk, Nadine Tung	2017	6
4	Choosing a BRCA Genetic Testing Laboratory: A Patient-Centric and Ethical Call to Action for Clinicians and Payers The American Journal of Managed Care ·Ellen Matloff, Rachel Barnett, Robert L. Nussbaum	2014	1
5	The Angelina Effect: Rising Interest in Genetic Testing Creates Opportunities for Patients-and Profit The American Journal of Managed Care ·Ellen Matloff	2014	1
6	“Would you test your children without their consent?” and other sticky dilemmas in the field of cancer genetic testing Familial Cancer ·Karina L. Brierley, A. M Adeyemi, Anne Moyer, Ellen Matloff	2014	2
7	Adverse Events in Cancer Genetic Testing The Cancer Journal ·A. M Adeyemi, Karina L. Brierley, Rachel Barnett, Susheela Yadav, Talia Donenberg, 義章石黒, Khanpour Hamzeh, Mira Prashar, Prajwal Ghadole, Li Ruidi, Jacquelyn M. Powers, Christine Stanislaw, P. Gaujé, Soojin Hwang, Ellen Matloff	2014	40
8	Adverse Events in Cancer Genetic Testing The Cancer Journal ·Karina L. Brierley, Tian Jing-kui, Shobhana, Mira Prashar, Taylor Stuart A, Christine Stanislaw, Ellen Matloff	2012	83
9	Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer? Journal of Clinical Oncology ·S. M. Domchek, Tara M. Friebel, Susan L. Neuhausen, Henry T. Lynch, CF Singer, Rosalind A. Eeles, Claudine Isaacs, Puster Rainardo Antonio, PA Ganz, Suratkal P. Shenoy, Jeffrey N. Weitzel, Michael Schachermayr, Wendy S. Rubinstein, Gail E. Tomlinson, E Oboda, Gurjasmine Kaur, Ellen Matloff, D. Gareth Evans, J. E. Garber, Timothy R. Rebbeck	2011	16
10	Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups Annals of Oncology ·Bruce G. Haffty, Doo Ho Choi, Sharad Goyal, Andrea Silber, Lydia Petráňová, Ellen Matloff, Joshua Radicke, Michael J. Nissenblatt, D. Toppmeyer, Meena S. Moran	2009	51
11	Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study Journal of Clinical Oncology ·Noah D. Kauff, Susan M. Domchek, Tara M. Friebel, Mark E. Robson, Johanna Lee, Judy E. Garber, Claudine Isaacs, D. Gareth Evans, Henry T. Lynch, Rosalind A. Eeles, Susan L. Neuhausen, Mary B. Daly, Ellen Matloff, Joanne L. Blum, Paul Sabbatini, Richard R. Barakat, Clifford A. Hudis, Larry Norton, Kenneth Offit, Timothy R. Rebbeck	2008	381
12	Bilateral Prophylactic Oophorectomy and Bilateral Prophylactic Mastectomy in a Prospective Cohort of Unaffected BRCA1 and BRCA2 Mutation Carriers Clinical Breast Cancer ·Tara M. Friebel, Susan M. Domchek, Susan L. Neuhausen, Theresa Wagner, D. Gareth Evans, Claudine Isaacs, Judy E. Garber, Mary B. Daly, Rosalind A. Eeles, Ellen Matloff, Gail E. Tomlinson, Henry T. Lynch, Nadine Tung, Joanne L. Blum, Jeffrey N. Weitzel, Wendy S. Rubinstein, Patricia A. Ganz, Fergus J. Couch, Timothy R. Rebbeck	2007	67
13	Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study The Lancet Oncology ·Susan M. Domchek, Tara M. Friebel, Susan L. Neuhausen, Theresa Wagner, D. Gareth Evans, Claudine Isaacs, Judy E. Garber, Mary B. Daly, Rosalind A. Eeles, Ellen Matloff, Gail E. Tomlinson, Laura van’t Veer, Henry T. Lynch, Olufunmilayo I. Olopade, Barbara Weber, Timothy R. Rebbeck	2006	216
14	Becoming a Daughter Journal of Genetic Counseling ·Ellen Matloff	2006	5
15	Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer Breast Cancer Research ·Susan A. Higgins, Ellen Matloff, David L. Rimm, James Dziura, Bruce G. Haffty, Bonnie L. King	2005	24
16	Germline PTEN Promoter Mutations and Deletions in Cowden/Bannayan-Riley-Ruvalcaba Syndrome Result in Aberrant PTEN Protein and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway The American Journal of Human Genetics ·Xiao-Ping Zhou, Kristin Waite, Robert Pilarski, Heather Hampel, Magali Fernandez, 靖田中, Majed Dasouki, Gerald L. Feldman, Victoria Rozas Scaramelli, Jennifer Ivanovich, Ellen Matloff, 正和砂子田, Mary Ella Pierpont, Donna Russo, Najah T. Nassif, Charis Eng	2003	199
17	Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations New England Journal of Medicine ·Timothy R. Rebbeck, Henry T. Lynch, Susan L. Neuhausen, Steven A. Narod, Laura van’t Veer, Judy E. Garber, D. Gareth Evans, Claudine Isaacs, Mary B. Daly, Ellen Matloff, Olufunmilayo I. Olopade, Barbara L. Weber Hit paper breakdown →	2002	1025
18	Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status The Lancet ·Bruce G. Haffty, von Gunhild, Atif J. Khan, Pradip M. Pathare, O. Lunyk, Bruce Turner, Peter M. Glazer, Barbara A. Ward, I Nyoman Latra, Ellen Matloff, A. Bale, 茜太田	2002	206
19	The breast surgeon’s role in BRCA1 and BRCA2 testing The American Journal of Surgery ·Ellen Matloff	2000	12
20	Framework for a proactive parent support group: The syracuse cystic fibrosis model Journal of Pediatric Health Care ·Ellen Matloff, Shaimaa El-Kholy	1996	6

About Ellen Matloff

Ellen Matloff is a scholar working on Genetics, Cancer Research, Reproductive Medicine, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine, having authored 45 papers that have together received 4.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (37 papers), Genomics and Rare Diseases (7 papers), Genomic variations and chromosomal abnormalities (7 papers), Cancer Genomics and Diagnostics (7 papers), Genetic factors in colorectal cancer (6 papers), Prenatal Screening and Diagnostics (6 papers), Breast Cancer Treatment Studies (4 papers) and Biomedical Ethics and Regulation (3 papers). The work is most often cited by research in Reproductive Medicine (1.1k citations), Genetics (3.3k citations), Cancer Research (1.2k citations), Pathology and Forensic Medicine (853 citations) and Oncology (856 citations). Ellen Matloff has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include D. Gareth Evans, Claudine Isaacs, Henry T. Lynch, Susan L. Neuhausen, Timothy R. Rebbeck, Mary B. Daly, Olufunmilayo I. Olopade, Judy E. Garber, Steven A. Narod and Tara M. Friebel. Their work appears in journals such as The Cancer Journal, Journal of Clinical Oncology, Familial Cancer, The American Journal of Managed Care and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact